SCHEMBL9763422

SCHEMBL9763422

COc1cccc(N(c2ccc(-c3ccccc3)cc2)c2ccc(-c3ccccc3)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 4/20 0.47
HSD17B1 P14061 3/20 0.47
MTNR1A P48039 4/20 0.47
MTNR1B P49286 4/20 0.47
PTGES O14684 1/20 0.46
ALOX5 P09917 1/20 0.46
TRPV1 Q8NER1 1/20 0.46
MAOB P27338 2/20 0.44
CA4 P22748 1/20 0.43
ABL1 P00519 1/20 0.43
ABCB1 P08183 1/20 0.43
BCR P11274 1/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
ALOX15 P16050 1/20 0.42
DYRK1A Q13627 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12463079 1.00 HSD17B2 (0.47) HSD17B2HSD17B1MTNR1AMTNR1BPTGES
SCHEMBL13136850 1.00 HSD17B2 (0.47) HSD17B2HSD17B1MTNR1AMTNR1BPTGES
SCHEMBL3442214 1.00 HSD17B2 (0.47) HSD17B2HSD17B1MTNR1AMTNR1BPTGES
SCHEMBL4324691 1.00 HSD17B2 (0.47) HSD17B2HSD17B1MTNR1AMTNR1BPTGES
SCHEMBL17372968 1.00 HSD17B2 (0.47) HSD17B2HSD17B1MTNR1AMTNR1BPTGES
SCHEMBL914300 0.98 CA4 (0.45) HSD17B2HSD17B1MTNR1AMTNR1BPTGES
SCHEMBL915801 0.98 CA4 (0.45) HSD17B2HSD17B1MTNR1AMTNR1BPTGES
SCHEMBL19275026 0.98 CA4 (0.45) HSD17B2HSD17B1MTNR1AMTNR1BPTGES
SCHEMBL9770735 0.95 HSD17B2 (0.47) HSD17B2HSD17B1MTNR1AMTNR1BMAOB
SCHEMBL9581431 0.94 ALKBH3 (0.46) HSD17B2HSD17B1MTNR1AMTNR1BPTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230130126-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed
US-5011906-A Photoconductive imaging members with N,N-bis(biarylyl)aniline charge transport polymers XEROX CORPORATION (US) 1991-04-30 US disclosed
US-4937165-A Photoconductive imaging members with N,N-bis(biarylyl)aniline charge transport polymers XEROX CORPORATION (US) 1990-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230130126-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, PER2, CRY2 HSD17B2 1462/4885HSD17B1 2490/4885MTNR1A 4271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.